Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

11.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
What is Cancer?02:12

What is Cancer?

13.9K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
13.9K
Cancer Survival Analysis01:21

Cancer Survival Analysis

633
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
633
Cancer Therapies02:49

Cancer Therapies

9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EpiATLAS - a reference for human epigenomic research.

bioRxiv : the preprint server for biology·2026
Same author

VO: The Vaccine Ontology.

Scientific data·2026
Same author

Androgen activity in the male embryonic hindbrain drives lethal PFA ependymoma.

Nature·2026
Same author

VO: The Vaccine Ontology.

bioRxiv : the preprint server for biology·2025
Same author

Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms.

Leukemia·2025
Same author

Overture: an open-source genomics data platform.

GigaScience·2025

Related Experiment Video

Updated: Jan 10, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

744

The ICGC ARGO data dictionary for standardizing global cancer clinical data.

Hardeep K Nahal-Bose1, Peter Lichter2, Ursula Weber2

  • 1Ontario Institute for Cancer Research (OICR), Toronto, ON, M5G 1M1, Canada.

Scientific Data
|November 20, 2025
PubMed
Summary

The International Cancer Genome Consortium Accelerating Research in Genomic Oncology (ICGC ARGO) project harmonizes clinical data for 100,000 cancer patients globally. This effort advances genomic oncology by standardizing data collection for precision cancer care.

More Related Videos

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.4K
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

2.6K

Related Experiment Videos

Last Updated: Jan 10, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

744
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.4K
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

2.6K

Area of Science:

  • Genomic Oncology
  • Cancer Research
  • Bioinformatics

Background:

  • The International Cancer Genome Consortium Accelerating Research in Genomic Oncology (ICGC ARGO) project aims to sequence 100,000 cancer genomes.
  • Integrating genomic data with clinical information is crucial for advancing cancer diagnosis, treatment, and prevention.
  • Harmonizing diverse clinical data across tumor types globally presents a significant challenge.

Purpose of the Study:

  • To develop a standardized data collection method for the ICGC ARGO project.
  • To ensure consistent, high-quality clinical data across diverse cancer types and international sites.
  • To facilitate the application of genomic insights in precision oncology.

Main Methods:

  • Development of the ICGC ARGO Data Dictionary, a minimal set of clinical fields.
  • Implementation of an event-based data model to capture clinical relationships and support longitudinal data collection.
  • Adherence to international standardized terminology and interoperability with standards like mCODE.

Main Results:

  • A harmonized clinical data collection framework for a large-scale international cancer genomics initiative.
  • Ensured consistency and quality of clinical data essential for genomic analysis.
  • Facilitated data integration and analysis across 22 tumor types and 13 countries.

Conclusions:

  • The ICGC ARGO Data Dictionary is vital for standardizing clinical data in large-scale genomic oncology research.
  • Its adoption by major global initiatives demonstrates its effectiveness in advancing precision oncology.
  • This standardization accelerates the translation of genomic discoveries into clinical practice.